Statin adherence and the risk of Parkinson's disease: A population-based cohort study

All for Statins and Statins for All; An Update

(2015) Aris P. Agouridis et al.   CURRENT PHARMACEUTICAL DESIGN

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

(2015) Xuemei Huang et al.   MOVEMENT DISORDERS

Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) method

(2015) Maarten J. Bijlsma et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Holding on to statins in Parkinson disease

(2013) E.-K. Tan et al.   NEUROLOGY

Discontinuation of statin therapy associates with Parkinson disease: A population-based study

(2013) Y.-C. Lee et al.   NEUROLOGY

Prospective Study of Statin Use and Risk of Parkinson Disease

(2012) Xiang Gao   ARCHIVES OF NEUROLOGY

Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias

(2012) Martin Wolkewitz et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Epidemiology and etiology of Parkinson’s disease: a review of the evidence

(2011) Karin Wirdefeldt et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

When Does Parkinson Disease Start?

(2010) Rodolfo Savica et al.   ARCHIVES OF NEUROLOGY

Statins: Multiple neuroprotective mechanisms in neurodegenerative diseases

(2010) Qing Wang et al.   EXPERIMENTAL NEUROLOGY

Statin use and Parkinson's disease in Denmark

(2010) Beate Ritz et al.   MOVEMENT DISORDERS

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

(2010) D. O. Claassen et al.   NEUROLOGY

Protopathic bias in observational studies on statin effectiveness

(2009) Maarit Jaana Korhonen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

(2009) A. Ghosh et al.   JOURNAL OF NEUROSCIENCE

Long-term persistence with statin treatment in a not-for-profit health maintenance organization: A population-based retrospective cohort study in Israel

(2008) Gabriel Chodick et al.   CLINICAL THERAPEUTICS

Use of Statins and the Risk of Parkinson???s Disease

(2008) Claudia Becker et al.   DRUG SAFETY

Statin use and the risk of Parkinson disease: a nested case control study

(2008) Ali Samii et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease

(2008) Pazit Bar-On et al.   JOURNAL OF NEUROCHEMISTRY

Statin use and the risk of Parkinson disease

(2008) A. D. Wahner et al.   NEUROLOGY

Immortal Time Bias in Pharmacoepidemiology

(2007) S. Suissa   AMERICAN JOURNAL OF EPIDEMIOLOGY